Novo Nordisk Foundation's CEO warns antibiotic resistance will be world's second-biggest killer

If we fail to act, the world will risk antibiotic resistance becoming far worse, with fatal consequences exceeding our collective imaginations, says CEO of the Novo Nordisk Foundation Mads Krogsgaard Thomsen, though he highlights some efforts are being made to combat the threat.

Mads Krogsgaard Thomsen, CEO at the Novo Nordisk Foundation. | Photo: Gregers Tycho/ERH

While the third and fourth Covid-19 waves are rolling in over the world like tsunamis, CEO of the Novo Nordisk Foundation Mads Krogsgaard Thomsen warns of another red flag.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs